Mannatechorporated Net Profit Margin 2006-2020 | MTEX

Mannatechorporated net profit margin from 2006 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Mannatechorporated Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-09-30 $0.15B $0.01B 5.26%
2020-06-30 $0.15B $0.01B 3.25%
2020-03-31 $0.16B $0.01B 3.82%
2019-12-31 $0.16B $0.00B 2.53%
2019-09-30 $0.16B 0 0.00%
2019-06-30 $0.17B $-0.00B -0.60%
2019-03-31 $0.17B $-0.00B -1.76%
2018-12-31 $0.17B $-0.00B -2.31%
2018-09-30 $0.18B $-0.01B -3.43%
2018-06-30 $0.17B $-0.00B -1.72%
2018-03-31 $0.18B $-0.00B -0.56%
2017-12-31 $0.18B $-0.00B -1.13%
2017-09-30 $0.17B $0.00B 0.57%
2017-06-30 $0.18B $0.00B 0.56%
2017-03-31 $0.18B $-0.00B -1.10%
2016-12-31 $0.18B 0 0.00%
2016-09-30 $0.18B $0.00B 1.64%
2016-06-30 $0.18B $0.00B 1.12%
2016-03-31 $0.18B $0.01B 3.39%
2015-12-31 $0.18B $0.01B 3.33%
2015-09-30 $0.18B $0.01B 3.33%
2015-06-30 $0.19B $0.01B 5.73%
2015-03-31 $0.19B $0.01B 3.66%
2014-12-31 $0.19B $0.01B 3.16%
2014-09-30 $0.19B $0.01B 3.65%
2014-06-30 $0.18B $0.00B 0.56%
2014-03-31 $0.18B $0.00B 1.68%
2013-12-31 $0.18B $0.00B 2.25%
2013-09-30 $0.17B $0.00B 0.58%
2013-06-30 $0.17B $0.00B 2.33%
2013-03-31 $0.17B $0.00B 0.58%
2012-12-31 $0.17B $-0.00B -0.57%
2012-09-30 $0.18B $-0.01B -4.44%
2012-06-30 $0.19B $-0.01B -7.45%
2012-03-31 $0.20B $-0.02B -8.72%
2011-12-31 $0.20B $-0.02B -10.45%
2011-09-30 $0.21B $-0.02B -8.17%
2011-06-30 $0.21B $-0.01B -6.60%
2011-03-31 $0.22B $-0.01B -5.94%
2010-12-31 $0.23B $-0.01B -4.80%
2010-09-30 $0.24B $-0.01B -2.46%
2010-06-30 $0.26B $-0.01B -5.38%
2010-03-31 $0.28B $-0.02B -5.71%
2009-12-31 $0.29B $-0.02B -6.21%
2009-09-30 $0.30B $-0.02B -6.42%
2009-06-30 $0.30B $-0.01B -3.30%
2009-03-31 $0.31B $-0.02B -4.81%
2008-12-31 $0.33B $-0.01B -3.61%
2008-09-30 $0.36B $-0.02B -4.79%
2008-06-30 $0.37B $-0.02B -4.01%
2008-03-31 $0.40B $-0.00B -0.50%
2007-12-31 $0.41B $0.01B 1.69%
2007-09-30 $0.42B $0.02B 4.51%
2007-06-30 $0.42B $0.03B 6.37%
2007-03-31 $0.42B $0.03B 8.15%
2006-12-31 $0.41B $0.03B 8.03%
2006-09-30 $0.41B $0.03B 8.40%
2006-06-30 $0.41B $0.03B 8.15%
2006-03-31 $0.40B $0.03B 7.44%
2005-12-31 $0.39B $0.03B 7.46%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.039B $0.158B
Mannatech Inc is a wellness solution provider that sells its products through a global network-marketing system throughout the United States and the international markets of Canada, Australia, the United Kingdom, Japan and New Zealand.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.544B 41.18
Takeda Pharmaceutical (TAK) Japan $57.821B 10.79
Astellas Pharma (ALPMY) Japan $26.791B 16.73
Eisai (ESALY) Japan $22.035B 19.20
UCB SA (UCBJF) Belgium $21.755B 0.00
Merck (MKGAF) Germany $20.982B 27.52
Catalent (CTLT) United States $15.351B 45.92
Grifols, S.A (GRFS) Spain $12.940B 14.82
Neurocrine Biosciences (NBIX) United States $9.079B 71.45
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.491B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.053B 13.01
IPSEN SA ADR (IPSEY) France $7.714B 0.00
Ionis Pharmaceuticals (IONS) United States $7.174B 70.29
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $6.650B 0.00
Orion OYJ (ORINY) Finland $6.272B 21.76
United Therapeutics (UTHR) United States $5.834B 12.42
Evotec AG (EVTCY) Germany $5.166B 351.11
PTC Therapeutics (PTCT) United States $4.358B 0.00
Hypermarcas (HYPMY) Brazil $3.888B 14.30
ChemoCentryx (CCXI) United States $3.863B 0.00
FibroGen (FGEN) United States $3.823B 0.00
Sage Therapeutics (SAGE) United States $3.569B 0.00
Nektar Therapeutics (NKTR) United States $3.099B 0.00
Cronos Group (CRON) Canada $3.042B 0.00
Revolution Medicines (RVMD) United States $2.773B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.693B 13.75
Pacira BioSciences (PCRX) United States $2.661B 57.78
Corcept Therapeutics (CORT) United States $2.657B 25.70
Xencor (XNCR) United States $2.264B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.861B 15.93
Trillium Therapeutics (TRIL) Canada $1.856B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.854B 0.00
Translate Bio (TBIO) United States $1.672B 0.00
USANA Health Sciences (USNA) United States $1.617B 14.23
Heron Therapeutics (HRTX) United States $1.594B 0.00
Ocular Therapeutix (OCUL) United States $1.338B 0.00
Endo (ENDP) Ireland $1.283B 1.95
Karyopharm Therapeutics (KPTI) United States $1.265B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.211B 8.42
Zogenix (ZGNX) United States $1.196B 0.00
Tilray (TLRY) Canada $1.154B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.126B 0.00
Indivior (INVVY) United States $1.099B 13.62
ImmunoGen (IMGN) United States $1.045B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.890B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.845B 0.00
Esperion Therapeutics (ESPR) United States $0.828B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.819B 0.00
VAXART, INC (VXRT) United States $0.797B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.696B 0.00
Radius Health (RDUS) United States $0.691B 0.00
Collegium Pharmaceutical (COLL) United States $0.647B 38.15
Aerie Pharmaceuticals (AERI) United States $0.597B 0.00
Organogenesis Holdings (ORGO) United States $0.569B 0.00
Chinook Therapeutics (KDNY) United States $0.566B 0.00
Flexion Therapeutics (FLXN) United States $0.560B 0.00
Ardelyx (ARDX) United States $0.551B 0.00
Siga Technologies (SIGA) United States $0.541B 15.20
Rigel Pharmaceuticals (RIGL) United States $0.517B 0.00
Akebia Therapeutics (AKBA) United States $0.450B 0.00
Molecular Templates (MTEM) United States $0.434B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.426B 0.00
Innate Pharma SA (IPHYF) France $0.412B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.399B 0.00
TherapeuticsMD (TXMD) United States $0.399B 0.00
Altimmune (ALT) United States $0.392B 0.00
DURECT (DRRX) United States $0.372B 0.00
Profound Medical (PROF) Canada $0.369B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.366B 9.55
Concert Pharmaceuticals (CNCE) United States $0.342B 0.00
Harpoon Therapeutics (HARP) United States $0.341B 0.00
Rafael Holdings (RFL) United States $0.335B 0.00
KalVista Pharmaceuticals (KALV) United States $0.330B 0.00
Redhill Biopharma (RDHL) Israel $0.330B 0.00
Calithera Biosciences (CALA) United States $0.330B 0.00
MEI Pharma (MEIP) United States $0.323B 0.00
Summit Therapeutics (SMMT) United States $0.317B 0.00
CASI Pharmaceuticals (CASI) United States $0.301B 0.00
Menlo Therapeutics (VYNE) United States $0.285B 0.00
Lannett Co Inc (LCI) United States $0.276B 7.30
Jounce Therapeutics (JNCE) United States $0.267B 0.00
Nature's Sunshine Products (NATR) United States $0.247B 15.94
CTI BioPharma (CTIC) United States $0.243B 0.00
IMV INC (IMV) Canada $0.236B 0.00
Alpine Immune Sciences (ALPN) United States $0.233B 0.00
Otonomy (OTIC) United States $0.227B 0.00
Aquestive Therapeutics (AQST) United States $0.226B 0.00
OptiNose (OPTN) United States $0.223B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.211B 0.00
Xeris Pharmaceuticals (XERS) United States $0.205B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.199B 0.00
Heat Biologics (HTBX) United States $0.177B 0.00
Taiwan Liposome (TLC) Taiwan $0.162B 0.00
Aclaris Therapeutics (ACRS) United States $0.149B 0.00
Champions Oncology (CSBR) United States $0.139B 0.00
Infinity Pharmaceuticals (INFI) United States $0.136B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.133B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.133B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.128B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.112B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.112B 0.00
ProPhase Labs (PRPH) United States $0.104B 0.00
MediWound (MDWD) Israel $0.100B 0.00
Lipocine (LPCN) United States $0.100B 0.00
India Globalization Capital (IGC) United States $0.092B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.086B 0.00
Sundial Growers (SNDL) Canada $0.086B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.083B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.082B 0.00
Biomerica (BMRA) United States $0.080B 0.00
Nutriband (NTRB) United States $0.075B 0.00
SCYNEXIS (SCYX) United States $0.073B 0.00
Novan (NOVN) United States $0.073B 0.00
ElectroCore (ECOR) United States $0.073B 0.00
Hemispherx BioPharma (AIM) United States $0.072B 0.00
KemPharm (KMPH) United States $0.071B 0.00
AgeX Therapeutics (AGE) United States $0.067B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.067B 0.00
Natural Alternatives (NAII) United States $0.065B 124.50
CV Sciences (CVSI) United States $0.064B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.063B 0.00
GTx (ONCT) United States $0.059B 0.00
Onconova Therapeutics (ONTX) United States $0.058B 0.00
Addex Therapeutics (ADXN) Switzerland $0.058B 0.00
Recro Pharma (REPH) United States $0.055B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
Forward Pharma (FWP) Denmark $0.048B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 23.08
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.045B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.044B 0.00
Vical (BBI) United States $0.036B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.036B 0.00
IsoRay (ISR) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.033B 0.00
Neos Therapeutics (NEOS) United States $0.031B 0.00
Can-Fite Biopharma (CANF) Israel $0.029B 0.00
Iterum Therapeutics (ITRM) Ireland $0.028B 0.00
PolarityTE (PTE) United States $0.028B 0.00
Regulus Therapeutics (RGLS) United States $0.027B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.026B 0.00
Midatech Pharma (MTP) United Kingdom $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.017B 28.19
Hancock Jaffe Laboratories (HJLI) United States $0.017B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.016B 0.00
Bio-Path Holdings (BPTH) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
RXi Pharmaceuticals (PHIO) United States $0.014B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.014B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Shineco (TYHT) China $0.010B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
JanOne (JAN) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00